ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank69
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P69
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q4 20255.08%
Q3 2025-17.61%
Q2 2025-25.54%
Q1 20257.47%
Q4 20241.11%
Q3 2024-2.78%
Q2 202449.46%
Q1 2024-36.15%
Q4 202329.08%
Q3 20237.87%
Q2 20235.08%
Q1 20235.09%
Q4 2022-1.19%
Q3 20226.11%
Q2 202272.11%
Q1 2022-48.43%
Q4 202122.20%
Q3 202126.86%
Q2 202149.37%
Q1 2021-31.01%
Q4 2020-37.52%
Q3 20201.49%
Q2 2020206.11%
Q1 2020-69.67%
Q4 2019-3.16%
Q3 20198.66%
Q2 20190.00%
Q3 20180.00%
Q1 20180.00%
Q3 20170.00%
Q1 20170.00%
Q1 20160.00%
Q2 20150.00%
Q1 20150.00%
Q3 20130.00%
Q1 20130.00%
Q3 20120.00%
Q1 20120.00%
Q1 20110.00%
Q1 20100.00%